Related Experiment Videos
Metabolic control and morbidity of type 2 diabetic patients in a general practice network
M Bouma1, J H Dekker, J T van Eijk
1Institute for Research in Extramural Medicine, Vrije Universiteit, Amsterdam, The Netherlands.
Insights
Improving care for Type 2 diabetes patients is crucial. Focus on managing cardiovascular risk factors alongside blood sugar control (HbA1c) to reduce complications.
Area of Science:
- Internal Medicine
- Cardiology
- Endocrinology
Background:
- Type 2 diabetes is a growing global health concern.
- Effective management requires addressing both glycaemic control and cardiovascular risk factors.
- Cardiovascular complications are a leading cause of morbidity and mortality in diabetic patients.
Purpose of the Study:
- To assess glycaemic control.
- To determine the prevalence of cardiovascular risk factors.
- To evaluate micro- and macrovascular complications in Type 2 diabetes patients within a general practice setting.
Main Methods:
- A cohort of 637 Type 2 diabetes patients was studied.
- 405 patients underwent extensive examinations.
- Data collected included HbA1c, blood pressure, lipid profiles, BMI, smoking status, and prevalence of retinopathy, microalbuminuria, angina, myocardial infarction, and heart failure.
Main Results:
- 56.6% of patients had HbA1c levels of 7% or higher.
- High prevalence of hypertension (59.8%) and dyslipidaemia (46.5%) was observed.
- Significant rates of microvascular (retinopathy 12.5%, microalbuminuria 27.0%) and macrovascular complications (angina 17.7%, myocardial infarction 11.4%, heart failure 10.7%) were found.
Conclusions:
- Current care for Type 2 diabetes patients requires enhancement.
- Management strategies must prioritize cardiovascular risk factors equally with glycaemic control.
- Integrated care focusing on comprehensive risk factor management is essential for improving patient outcomes.
Methods:
Glycaemic control and the prevalence of modifiable cardiovascular risk factors, and micro- and macrovascular morbidity was examined in 637 Type 2 diabetic patients in general practice, of whom 405 consented to undergo a more extensive examination.
Results:
In these 405 patients, HbA1c was > or = 7% in 56.6%, and hypertension and dyslipidaemia were found in 59.8% and 46.5% of the patients, respectively. The level of cardiovascular risk factors was acceptable, according to the European guidelines, in the following proportions of patients: BMI 45.0%; total cholesterol 69.1%; HDL-cholesterol 68.1%; triglycerides 67.8%; current blood pressure 89.8%; and smoking 21.0%. Retinopathy was present in 12.5% and microalbuminuria in 27.0% of the patients. In all 637 patients, the prevalence of angina pectoris was 17.7%, of myocardial infarction 11.4% and of congestive heart failure 10.7%.
Conclusion:
The care for Type 2 diabetic patients needs improvement and should focus on cardiovascular risk factors as much as on glycaemic control.